IP Library Granted Patent US 12,350,395
Granted Patent B2
US 12,350,395 · App. 17/594,183 · Granted Jul 8, 2025

Process and device for generating a moving front within a sterilization monitoring device and uses thereof

Inventors: G. Marco Bommarito (Stillwater, MN); Scott D. Anderson (Lakeland, MN); Ryan W. Clarke (Woodbury, MN); Paul N. Holt (St. Paul, MN); William E. Foltz (Cottage Grove, MN); Timothy J. Nies (Stillwater, MN); Kevin D. Landgrebe (Woodbury, MN); Jeffrey D. Cotton (St. Paul, MN); Ryan T. Woldt (Minneapolis, MN)
Assignee: Solventum Intellectual Properties Company
A61L2/28G01N31/22A61L2/208
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,350,395
App. No.
17/594,183
Granted
Jul 8, 2025
Kind
B2
Abstract

The disclosed sterilization monitoring device comprises a perfusion channel with a chemical indicating composition disposed in fluid communication with the perfusion channel. Exposure to a sterilant creates a laterally moving front across the chemical indicating composition in the perfusion channel.

Claims (20)

1. A sterilization monitoring device comprising:

at least one perfusion channel comprising a first end and a second end, wherein at least one of the first end or the second end are open to the environs, wherein the at least one perfusion channel further comprises a height defined by a first side wall and a second side wall extending between a ceiling portion and a floor portion, a width, and a length; and

at least one chemical indicating composition carrier comprising at least one chemical indicating composition, wherein the at least one chemical indicating composition carrier is configured to be selectively in the at least one perfusion channel such that the at least one chemical indicating composition is in fluid communication with the at least one perfusion channel and extending along at least a portion of the at least one perfusion channel,

wherein the at least one perfusion channel creates a laterally moving front of a sterilant across the at least one chemical indicating composition,

wherein the at least one perfusion channel defines a fluid pathway over a top surface of the at least one chemical indicating composition,

wherein any combination of the height, the width, and/or the length of the at least one perfusion channel are dimensioned to generate lateral movement of the sterilant from the environs through the at least one perfusion channel.

2. The sterilization monitoring device of claim 1 , wherein the height and the width of the at least one perfusion channel are substantially constant along at least a portion of the length of the at least one perfusion channel.

3. The sterilization monitoring device of claim 1 , wherein the at least one chemical indicating composition is substantially isolated from the environs other than through the laterally moving front created by the at least one perfusion channel.

4. The sterilization monitoring device of claim 1 , wherein the first end is configured to substantially eliminate any perfusion of the sterilant into the at least one perfusion channel except for perfusion into the fluid pathway that extends laterally over a top surface of the at least one chemical indicating composition.

5. The sterilization monitoring device of claim 1 , wherein a portion of an upper section of a housing forms the ceiling portion of the at least one perfusion channel.

6. The sterilization monitoring device of claim 5 , wherein a lower section of the housing forms a floor portion of the at least one perfusion channel.

7. The sterilization monitoring device of claim 1 , wherein the chemical indicating composition is disposed along at least a portion of the floor portion of the at least one perfusion channel.

8. The sterilization monitoring device of claim 1 , wherein at least a portion of the ceiling portion forming the at least one perfusion channel is transparent.

9. The sterilization monitoring device of claim 2 , wherein a distance between the first end of the perfusion channel with the chemical indicating composition defines a perfusion length.

10. The sterilization monitoring device of claim 1 , wherein the at least one chemical indicating composition carrier further comprises an end being substantially aligned with the first end of the at least one perfusion channel.

11. The sterilization monitoring device of claim 1 , wherein the at least one chemical indicating composition when in fluid contact with the sterilant undergoes an oxidation reduction reaction.

12. The sterilization monitoring device of claim 1 , wherein the sterilant is vaporized hydrogen peroxide.

13. The sterilization monitoring device of claim 1 , wherein a ratio of the width of the least one perfusion channel to the height of at least one perfusion channel is at least 4:1.

14. The sterilization monitoring device of claim 1 , wherein the at least one perfusion channel defines a void space that is open to the environs.

15. The sterilization monitoring device of claim 1 , wherein the sterilant is steam.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 1, 2024
From: 3M INNOVATIVE PROPERTIES COMPANY
To: SOLVENTUM INTELLECTUAL PROPERTIES COMPANY
Reel/Frame 066430/0149 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 6, 2021
From: BOMMARITO, G. MARCO; ANDERSON, SCOTT D.; CLARKE, RYAN W.; HOLT, PAUL N.; FOLTZ, WILLIAM E.; NIES, TIMOTHY J.; LANDGREBE, KEVIN D.; COTTON, JEFFREY D.; WOLDT, RYAN T.
To: 3M INNOVATIVE PROPERTIES COMPANY
Reel/Frame 057711/0712 →
Continuity (2)
Provisional Application 62839446 · Apr 26, 2019
Related Publication 20220160920A1 · May 26, 2022
References Cited (22)
US 4138216A · Larsson · 1979 [cited by applicant]
US 4145186A · Anderson · 1979 [cited by applicant]
US 4579715A · Bruso · 1986 [cited by applicant]
US 5872004A · Bolsen · 1999 [cited by applicant]
US 6485979B1 · Kippenhan · 2002 [cited by applicant]
US 6897059B2 · Foltz · 2005 [cited by applicant]
US 7045343B2 · Witcher · 2006 [cited by applicant]
US 7247482B2 · Lemus · 2007 [cited by applicant]
US 7481975B2 · Read · 2009 [cited by applicant]
US 7927866B2 · Justi · 2011 [cited by applicant]
US 8343768B2 · Kyung-Hee Song et al. · 2013 [cited by applicant]
US 9017994B2 · Franciskovich · 2015 [cited by applicant]
US 10119946B2 · Bala et al. · 2018 [cited by applicant]
US 10947577B2 · Ahimou et al. · 2021 [cited by applicant]
US 20030215923A1 · Witcher · 2003 [cited by applicant]
CN 207562134U · 2018 [cited by applicant]
CN 207722140U · 2018 [cited by applicant]
EP 0428245 · 1991 [cited by applicant]
EP 2362786 · 2011 [cited by applicant]
WO WO2002087639 · 2002 [cited by applicant]
WO WO2020128956 · 2020 [cited by applicant]
International Search Report for PCT International Application No. PCT/IB2019/060945, mailed on Jun. 25, 2020, 4 pages. [cited by applicant]